CapEdge
Loading...
Advanced
What's new? Log in Free sign up
  • Home
  • Sectors & IndustriesSectors
  • Earnings
  • IPOs
  • SPACs
  • Transcripts
  • Insider
  • Institutional
  • Crypto
  • Screeners
  • Reddit
  • Splits
  • IMV Dashboard
  • Financials
  • Filings
  • Transcripts
  • ETFs
  • Institutional
  • Shorts
  • News
  • Reddit
  • 6-K Filing

IMV (IMV) 6-KReport of Foreign Private Issuer for the Month of October, 2021

Filed: 1 Oct 21, 9:30am
Free signup for more
  • Track your favorite companies
  • Receive email alerts for new filings
  • Personalized dashboard of news and more
  • Access all data and search results
Sign up for free
Search this filing
?
Pre-defined:
Table of contents
    Filing tables
    Export all tables to Excel
    Filing exhibits
    SEC
    • 6-K Current report (foreign)
    • 99.1 News Release Dated October 1, 2021
    IMV similar filings
    • 9 Nov 21 Translational Data From the DeCidE1 Clinical Study in Patients with Advanced, Recurrent Ovarian Cancer to be Presented at SITC Annual Meeting
    • 4 Nov 21 Report of Foreign Private Issuer for the Month of November, 2021
    • 7 Oct 21 Report of Foreign Private Issuer for the Month of October, 2021
    • 1 Oct 21 Report of Foreign Private Issuer for the Month of October, 2021
    • 1 Oct 21 IMV’s DPX Delivery Technology to be Showcased in Two e-Posters at the AACR-NCI-EORTC Conference on Molecular Targets and Cancer Therapeutics
    • 1 Sep 21 IMV Inc. to Present at Three Investor Conferences in September
    • 11 Aug 21 IMV Inc. Announces Second Quarter 2021 Financial and Operational Results
    Filing view
    Share this filing



    UNITED STATES
    SECURITIES AND EXCHANGE COMMISSION
    Washington, D.C. 20549

    FORM 6-K

    REPORT OF FOREIGN PRIVATE ISSUER PURSUANT TO RULE 13a-16 OR 15d-16
    UNDER THE SECURITIES EXCHANGE ACT OF 1934

    For the month of October, 2021

    Commission File Number: 001-38480

    IMV Inc.
    (Name of registrant)

    130 Eileen Stubbs Avenue, Suite 19 Dartmouth, Nova Scotia B3B 2C4, Canada

    Indicate by check mark whether the registrant files or will file annual reports under cover of Form 20-F or Form 40-F.

    [   ] Form 20-F [ X ] Form 40-F

    Indicate by check mark if the registrant is submitting the Form 6-K in paper as permitted by Regulation S-T Rule 101(b)(1): [   ]

    Indicate by check mark if the registrant is submitting the Form 6-K in paper as permitted by Regulation S-T Rule 101(b)(7): [   ]






    SIGNATURES

    Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized.

     IMV Inc.
     
    Date: October 1, 2021By:/s/ Pierre Labbé
     Name: Pierre Labbé
     Title: Chief Financial Officer

     





    Form 6-K Exhibit Index

    Exhibit
    Number
    Document Description
    99.1News Release dated October 1, 2021. Potential Response Predictors to IMV's Lead Compound in the DeCidE Clinical Study in Patients with Advanced, Recurrent Ovarian Cancer to be Presented at SITC Annual Meeting.

     



    Finsight
    Resources
    • Knowledgebase
    • Log In
    • Register
    Company
    • About
    • Contact
    • Solutions
    Products
    • Deal Roadshow
    • DealVDR
    • Evercall
    • Finsight.com
    CapEdge
    • Earnings Calendar
    • Earnings Transcripts
    • EDGAR Filing Screener
    • IPO Calendar
    • Compliance
    • Privacy
    • Security
    • Terms
    AngelList LinkedIn